
Morgan Roupret
@mroupret
Professor of Urology @HopPitieSalpe @APHP @Sorbonne_Univ_ Paris France 🇫🇷 Editor-in-Chief @EurUrolOncol @Uroweb & CCAFU chairman @AFUrologie - Views my own
ID: 184405393
https://euoncology.europeanurology.com/ 29-08-2010 13:32:50
12,12K Tweet
6,6K Followers
926 Following

❓Interested in intravesical therapy for bladder cancer? 🙋Join us tomorrow at #EAU25 in a great thematic session led by Maria J. Ribal & Morgan Roupret 🤝With my friend Antoni Vilaseca, but different positions 🔝Speakers Peter Black Evanguelos Xylinas Marco Moschini among others


📻STAY TUNED!!! 📹#UROONCODISCUSSIONS by TransworldHealth 🦀All about bladder cancer 🔜Dynamic discussions 🔝World experts Evanguelos Xylinas Antoni Vilaseca Morgan Roupret Óscar Rodríguez Faba Shahrokh F. Shariat Joan Palou Redorta Álvaro Pinto Andrea Necchi Sarah P. Psutka MD MS Enrique Grande Syed A Hussain



🔥 #EAU25 Madrid, 🇪🇸! Cutting edge insights European Association of Urology (EAU) Congress, reuniting with mentors & friends, exploring vibrant streets! Grateful for energy & connections! Benoît Peyronnet Dr. Wissam Kamal Morgan Roupret Saeed Bin Hamri


Great #EAU25 gala dinner at #galeriacristal #Madrid a pleasure to share a night with the great European Urology Oncology editorial team Morgan Roupret Alicia Morgans, MD, MPH Elena Castro Alessandro Volpe Riccardo Campi Jeremy Teoh


Fantastic #EAU25 with great science, productive meetings and catch up with friends. Goodbye Madrid 🇪🇸. Till next time 👋🏾 BURST Urology, Team #COMPASS UCL European Association of Urology (EAU)


A real-world evidence study by Morgan Roupret evaluating prevalence of FGFR aterations in patients with IRNMIBC, as defined by Prof Ashish M. Kamat, MD, MBBS Prof Wei Shen Tan and colleagues from International Bladder Cancer Group (IBCG) IBCG Implications for patient selection for

Fantastic experience at #EAU25 combining science, friendship, and brainstorming on future projects I am deeply thankful for the opportunity to contribute to the European Association of Urology (EAU) A special thanks 🙏to European Urology Oncology Morgan Roupret EAU-YAU Renal Cancer Working Group #EAUGuidelinesRCC & all friends and


Just out in European Urology 👌 @martinmiszcyk ⏩Many patients with mUC selected for MDT achieve long-term survival, particularly those with lung metastases ⏩MDT emerges as a promising research direction, with novel systemic therapies capable of eliciting sustained responses


Day 1 ESMO - Eur. Oncology #Preceptorship in Metastatic #urothelial #RCC #cancer 62 participants from 26 countries selected out of >230 applicants ! Thanks to the faculty for sharing #SOC ESMO - Eur. Oncology #guidelines


🌟Avec Morgan Roupret nous parlerons de la gestion de la cystite radique. 🌟Tous les renseignements sur ce Webinar sont accessibles via le QR code ✅


Proud to serve as faculty at the ESMO - Eur. Oncology GU Preceptorship in Zurich — great discussions, brilliant participants & lots of energy! Laurence Albiges Grunwald Bernadett Szabados ylt Morgan Roupret @suarez Guillermo de Velasco Ursula Vogl @zschabit A.Bex,C. Suarez,S. Zschabitz OncoDaily AIOM


Laurence Albiges ESMO - Eur. Oncology Viktor Grünwald Guillermo de Velasco Patrizia Giannatempo Morgan Roupret Cris Bernadett Szabados Ursula Vogl A lot of passionnate discussions and interaction with other faculty members and attendees !

Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2–5 pm 🗓️ #AUA25 Amer. Urol. Assn. IBCG Kelly Bree Petros Grivas Laura Bukavina Shilpa Gupta Neha Vapiwala Wes Kassouf Peter Black Patrick Hensley, MD Hikmat Al Ahmadie Joshua Meeks Benjamin Pradere Sia Daneshmand, M.D. Vignesh Packiam, MD


Best #AUA25 event hands down.. Ready to debate French sensation 🇫🇷 Morgan Roupret 🥖 about all things bladder

🎥En bloc laser resection of 3 bladder tumors at ROC Clinic HM HOSPITALES assisted by the fantastic Ghali Belkahia ⛔️Multiplicity should not be a contraindication for en bloc 🔬Easier evaluation for our pathologists ⬆️Muscle in the specimen ⬇️Recurrence as shown by


Nouvel événement! Nouveau public ! Nouvelles données ! AFUF Paul Sargos Tribunek_Onco

Our new SR and MA published in European Urology Oncology evaluates focal therapy for localized PCa using prospective data only. Important for patient counselling. 📊 50 studies, 4,615 patients 📊 12-mo csPCa RFS in intermediate-risk: 79% (95% CI 74–83%) 🔗 doi.org/10.1016/j.euo.…


Thanks for the shout-out in AUA News – much appreciated! #AUA25 Amer. Urol. Assn. auadailynews.org/previews/artic… IBCG Dave Penson
